WT
BPMC

Whittier Trust’s Blueprint Medicines BPMC Stock Holding History

Whittier Trust’s Portfolio BPMC Stock Details BPMC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-17
Closed -$1K – 1690
2022
Q1 		$1K Buy
+17
New +$1.22K ﹤0.01% 1627
2019
Q4 		– Sell
-1,632
Closed -$120K – 1522
2019
Q3 		$120K Buy
1,632
+600
+58% +$51.9K ﹤0.01% 646
2019
Q2 		$97K Buy
+1,032
New +$85.2K ﹤0.01% 661

Other funds holding BPMC

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Whittier Trust's BPMC Position: Q2 2022 in Review

Whittier Trust sold out of Blueprint Medicines (BPMC) in Q2 2022, closing a stake of 17 shares — an estimated $1K sold.

Whittier Trust first reported a position in BPMC in Q2 2019 and held it in 3 quarters. The position peaked at $120K in Q3 2019. 237 funds tracked by Wall St. Rank hold BPMC as of Q2 2022.

  • Whittier Trust reported no remaining Blueprint Medicines position as of Q2 2022 after selling out during the quarter.
  • Whittier Trust sold 17 Blueprint Medicines shares in Q2 2022, an estimated $1K.
  • Whittier Trust first reported a position in Blueprint Medicines in Q2 2019 and held it in 3 quarters.
  • Whittier Trust's Blueprint Medicines position peaked at $120K in Q3 2019.
  • 237 funds tracked by Wall St. Rank held Blueprint Medicines as of Q2 2022.

Based on Whittier Trust's 13F filing for Q2 2022, filed 28 Jul 2022.